한빛사
>
한빛사논문
한빛사논문
- 조회184
Biomaterials, Jan 25 2025, 318 S0142-9612(25)00065-1 | https://doi.org/10.1016/j.biomaterials.2025.123146
Ultrasonic disruption of circulating amyloid β aggregates via phase-change peptide nanoemulsions
Inhye Kim a, Scott H. Medina a,b
aDepartment of Biomedical Engineering, Pennsylvania State University, University Park, PA, 16802-4400, USA
bHuck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, 16802-4400, USA
Corresponding author : Scott H. Medina
aDepartment of Biomedical Engineering, Pennsylvania State University, University Park, PA, 16802-4400, USA
bHuck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, 16802-4400, USA
Corresponding author : Scott H. Medina
Abstract
Amyloid β (Aβ) assemblies exist not only in the central nervous system, but can circulate within the bloodstream to trigger and exacerbate peripheral, cerebrovascular, and neurodegenerative disorders. Eliminating excess peripheral Aβ fibrils, therefore, holds promise to improve the management of amyloid-related diseases. Here, we present nanoemulsion-mediated ultrasonic ablation of circulating Aβ fibrils to both destroy established plaques and prevent the re-growth of ablated fragments back into toxic species. This approach is made possible using a de novo designed peptide emulsifier that contains the self-associating sequence from the amyloid precursor protein. Emulsification of the peptide surfactant with fluorous nanodroplets produces contrast agents that rapidly adsorb Aβ assemblies and allows their ultrasound-controlled destruction via acoustic cavitation. Vessel-mimetic flow experiments demonstrate that nanoemulsion-assisted Aβ disruption can be achieved in circulation using clinical diagnostic ultrasound transducers. Additional cell-based assays confirm the ablated fragments are less toxic to neuronal and glial cells compared to mature fibrils, and can be rapidly phagocytosed by both peripheral and brain macrophages. These results highlight the potential of nanoemulsion contrast agents to deliver new imaging enabled strategies for non-invasive management of Aβ-related diseases using traditional diagnostic ultrasound modalities.
논문정보
- Research article
- 2025년 01월 (BRIC 등록일 2025-02-13)
- 국외 연구진
- 바이오·의료융합 > 바이오센싱 및 나노바이오물질
댓글 작성 로그인
팝업 닫기관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기
